Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
Crossref DOI link: https://doi.org/10.1186/s40164-016-0061-2
Published Online: 2017-01-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moschetta, Michele
Mak, Gabriel
Hauser, Joana
Davies, Catriona
Uccello, Mario
Arkenau, Hendrik-Tobias